EQBK
Equity Bancshares, Inc.
EQBK's fundamentals are strong: revenue grew 65% and its operating margin rose 26 points to 36%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
EQBK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
EQBK's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like EQBK.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
EQBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.4x | $37.06 | -24% |
| Forward | 9.4x | $49.06 | — |
| Fair | 9.9x | $43.90 | -11% |
| Current | 11x | $49.06 | — |
| Expensive | 31x | $138 | +182% |
Historical ranges are pointers, not guarantees.
EQBK has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
EQBK Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for EQBK, but weaker profitability.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over EQBK on the outlook, with more favorable profitability expectations.
EQBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.22 | +18% |
| Q3 2026 | $4.43 | +263% |
| Q2 2026 | $1.59 | -61% |
| Q1 2026 | $1.18 | -70% |
| Q4 2025 | $1.23 | -69% |
| Q3 2023 | $3.02 | -11% |
| Q2 2023 | $3.15 | -3.1% |
| Q1 2023 | $3.35 | +0.3% |
| Q4 2022 | $3.51 | +2.3% |
EQBK's earnings per share have jumped to their highest in six years: $4.43 over the past year, up from $1.22 the year before. Its recent earnings include one-off gains.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over EQBK on earnings, with more consistent year-over-year improvement.
EQBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $83.7M | +365% |
| Q2 2026 | $81.9M | +40% |
| Q1 2026 | $83.2M | +37% |
| Q4 2025 | $73M | +25% |
| Q3 2025 | $18M | -67% |
| Q2 2025 | $58.4M | +5.3% |
| Q1 2025 | $60.6M | +8.4% |
| Q3 2024 | $55.3M | +11% |
EQBK's revenue has grown year over year for four quarters in a row: $84M last quarter, up 365% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 41% | +248 points |
| Q2 2026 | 41% | +9.7 points |
| Q1 2026 | 27% | -4.4 points |
| Q4 2025 | 36% | +1.3 points |
| Q3 2025 | -207% | -250 points |
| Q2 2025 | 31% | +2.1 points |
| Q1 2025 | 31% | -0.7 points |
| Q4 2024 | 35% | N/A |
EQBK has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
EQBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.9M | +123% |
| Q2 2026 | $35.5M | +37% |
| Q1 2026 | $11.5M | -43% |
| Q4 2025 | -$12.5M | -163% |
| Q3 2025 | $4.5M | -77% |
| Q2 2025 | $26M | +71% |
| Q1 2025 | $20.2M | +90% |
| Q3 2024 | $19.7M | -0.9% |
EQBK has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
EQBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -22.7K shares |
| 1 year | +8.7% | +1.7M shares |
| 3 years | +34% | +5.2M shares |
| 5 years | +42% | +6.1M shares |
| Available history | +31% | +5M shares |
EQBK has 21M diluted shares, up 8.7% from a year ago, despite $40M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $9.9M |
| Q1 2026 | $22.7M |
| Q4 2025 | $7.2M |
| Q3 2025 | $6.5M |
| Q2 2025 | $274,000 |
| Q1 2025 | — |
| Q4 2024 | — |
EQBK spent $40M buying back its own shares over the past year, about six times what it spent the year before.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over EQBK on shareholder dilution, with a more favorable share count trend.
EQBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.6x | Healthy |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -2.1x | Net Cash |
| Q4 2025 | -5.1x | Net Cash |
| Q3 2025 | -8.1x | Net Cash |
| Q2 2025 | 1.0x | Very low |
| Q1 2025 | -0.6x | Net Cash |
| Q4 2024 | -0.9x | Net Cash |
EQBK has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
EQBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.7 | Neutral |
| Stochastic | 45.4 | Neutral |
EQBK's weekly RSI is 54 (neutral) and its Stochastic is 45 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
EQBK PE vs Financial Services Sector
| Metric | EQBK | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 15% below |
| PE % | 70 | 63 | 7 pts above |
EQBK has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
EQBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $48.2 | 1.8% above |
| 20 week MA | $49.3 | 0.5% below |
| 50 week MA | $47.2 | 4% above |
| 100 week MA | $43.9 | 12% above |
| 200 week MA | $37.8 | 30% above |
EQBK has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
EQBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.5 | $21.3 | -30% |
| 2021 | $21.3 | $33.3 | +56% |
| 2022 | $33.3 | $32.9 | -1.3% |
| 2023 | $32.9 | $33.9 | +3.2% |
| 2024 | $33.9 | $42.7 | +26% |
| 2025 | $42.7 | $45.7 | +6.9% |
| 2026 YTD | $45.7 | $49.1 | +7.5% |
EQBK has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.